Lista de obras - Sara Bravaccini - Dominio Público Uruguay

111In-Pentetreotide (OctreoScan) scintigraphy in the staging of small-cell lung cancer: its accuracy and prognostic significance

artículo científico publicado en 2015

ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients

artículo científico publicado en 2020

ALK translocation detection in non-small cell lung cancer cytological samples obtained by TBNA or EBUS-TBNA.

artículo científico publicado en 2015

Accuracy of urine telomerase activity to detect bladder cancer in symptomatic patients

artículo científico publicado en 2009

Are fine-needle aspiration biopsy-derived cell blocks a useful surrogate for tissue samples in breast cancer?

artículo científico publicado en 2018

Are we ready to use TMB in breast cancer clinical practice?

scientific article published on 28 July 2020

Assessment of DNA damage and telomerase activity in exfoliated urinary cells as sensitive and noninvasive biomarkers for early diagnosis of bladder cancer in ex-workers of a rubber tyres industry.

artículo científico publicado en 2014

Benefit from anthracyclines in relation to biological profiles in early breast cancer.

artículo científico publicado en 2014

Biofunctional characteristics of in situ and invasive breast carcinoma.

artículo científico publicado en 2013

CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?

artículo científico publicado en 2019

Carbonic Anhydrase XII Expression Is Modulated during Epithelial Mesenchymal Transition and Regulated through Protein Kinase C Signaling

scientific article published on 22 January 2020

Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer

artículo científico publicado en 2020

Clinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence

Combining cytology, TRAP assay, and FISH analysis for the detection of bladder cancer in symptomatic patients

artículo científico publicado en 2011

Detection of HER2 and Topo 2 in breast cancers: comparison between MLPA and FISH approaches

artículo científico publicado en 2011

Development and characterization of a monoclonal antibody directed against human telomerase reverse transcriptase (hTERT).

artículo científico publicado en 2005

Differences in biological features of breast cancer between Caucasian (Italian) and African (Tanzanian) populations

artículo científico publicado en 2014

Epithelial-to-mesenchymal transition and EGFR status in NSCLC: the role of vimentin expression

scientific article published on 01 February 2019

Evaluating the appropriateness of chemotherapy in a low-resource cancer centre in sub-Saharan Africa

scientific article published on 13 November 2019

Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer?

artículo científico publicado en 2019

Explaining the aggressiveness of breast cancer in sub-Saharan African patients

scientific article published on 13 August 2019

Is Ki67 still a powerful ally in predicting the clinical benefit of anthracyclines for the adjuvant treatment of early breast cancer?

artículo científico publicado en 2018

Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience

artículo científico publicado en 2020

Long-term complete response in a patient with liver metastases from breast cancer treated with metronomic chemotherapy

artículo científico publicado en 2014

Microbiota-Derived Metabolites in Tumor Progression and Metastasis

scientific article published on 12 August 2020

Molecular determinations of EGFR and EML4-ALK on a single slide of NSCLC tissue

artículo científico publicado en 2013

New biomarkers to predict the evolution of in situ breast cancers

artículo científico publicado en 2014

Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy.

artículo científico publicado en 2015

Palbociclib (PD 0332991) : targeting the cell cycle machinery in breast cancer

artículo científico publicado en 2013

Paraneoplastic lipase and amylase production in a patient with small-cell lung cancer: case report

artículo científico publicado en 2016

Petals and thorns in programmed death-ligand 1 testing: Is all non-small cell lung cancer diagnostic material suitable?

artículo científico publicado en 2018

Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy

artículo científico

Potential of telomerase expression and activity in cervical specimens as a diagnostic tool

artículo científico publicado en 2005

Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: a single center study.

artículo científico publicado en 2012

Predictive role of telomerase activity in the clinical outcome of patients with benign lesions of the uterine cervix or CIN.

artículo científico publicado en 2012

Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cells

artículo científico publicado en 2005

Relevance of Urine Telomerase in the Diagnosis of Bladder Cancer

scientific article published in The Journal of the American Medical Association

Role of androgen and estrogen receptors as prognostic and potential predictive markers of ductal carcinoma in situ of the breast

artículo científico publicado en 2015

Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy

scientific article published on 02 September 2019

The Role of CXCR4 in the Prediction of Bone Metastases from Breast Cancer: A Pilot Study

artículo científico publicado en 2011

The current role of telomerase in the diagnosis of bladder cancer

artículo científico publicado en 2009

Triple negative breast cancer in a poor resource setting in North-Western Tanzania: a preliminary study of 52 patients ⬇️

artículo científico publicado en 2014

Urinary biomarkers of non-muscle-invasive bladder cancer: current status and future potential

artículo científico publicado en 2012

Urine Telomerase Activity for the Detection of Bladder Cancer in Females

artículo científico publicado en 2007

Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary data

artículo científico publicado en 2012

Urine telomerase: an important marker in the diagnosis of bladder cancer

artículo científico publicado en 2004

Usefulness of immunological detection of the human telomerase reverse transcriptase

artículo científico publicado en 2005

What Influences the Choice of Ibrutinib-Rituximab vs Classic Chemoimmunotherapy for Chronic Lymphocytic Leukemia?

scientific article published on 01 January 2020

What impacts the cost-effectiveness of PD-L1 testing in non-small cell lung cancer?

artículo científico publicado en 2019

What is the best clinical pathological score to identify high-risk patients with lobular carcinoma of the breast who are likely to benefit from adjuvant chemotherapy?

artículo científico publicado en 2019

What to look for in cell-free DNA from breast cancer patients

artículo científico publicado en 2018

Lista de obras de Sara Bravaccini

111In-Pentetreotide (OctreoScan) scintigraphy in the staging of small-cell lung cancer: its accuracy and prognostic significance

ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients

ALK translocation detection in non-small cell lung cancer cytological samples obtained by TBNA or EBUS-TBNA.

Accuracy of urine telomerase activity to detect bladder cancer in symptomatic patients

Are fine-needle aspiration biopsy-derived cell blocks a useful surrogate for tissue samples in breast cancer?

Are we ready to use TMB in breast cancer clinical practice?

Assessment of DNA damage and telomerase activity in exfoliated urinary cells as sensitive and noninvasive biomarkers for early diagnosis of bladder cancer in ex-workers of a rubber tyres industry.

Benefit from anthracyclines in relation to biological profiles in early breast cancer.

Biofunctional characteristics of in situ and invasive breast carcinoma.

CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?

Carbonic Anhydrase XII Expression Is Modulated during Epithelial Mesenchymal Transition and Regulated through Protein Kinase C Signaling

Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer

Clinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence

Combining cytology, TRAP assay, and FISH analysis for the detection of bladder cancer in symptomatic patients

Detection of HER2 and Topo 2 in breast cancers: comparison between MLPA and FISH approaches

Development and characterization of a monoclonal antibody directed against human telomerase reverse transcriptase (hTERT).

Differences in biological features of breast cancer between Caucasian (Italian) and African (Tanzanian) populations

Epithelial-to-mesenchymal transition and EGFR status in NSCLC: the role of vimentin expression

Evaluating the appropriateness of chemotherapy in a low-resource cancer centre in sub-Saharan Africa

Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer?

Explaining the aggressiveness of breast cancer in sub-Saharan African patients

Is Ki67 still a powerful ally in predicting the clinical benefit of anthracyclines for the adjuvant treatment of early breast cancer?

Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience

Long-term complete response in a patient with liver metastases from breast cancer treated with metronomic chemotherapy

Microbiota-Derived Metabolites in Tumor Progression and Metastasis

Molecular determinations of EGFR and EML4-ALK on a single slide of NSCLC tissue

New biomarkers to predict the evolution of in situ breast cancers

Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy.

Palbociclib (PD 0332991) : targeting the cell cycle machinery in breast cancer

Paraneoplastic lipase and amylase production in a patient with small-cell lung cancer: case report

Petals and thorns in programmed death-ligand 1 testing: Is all non-small cell lung cancer diagnostic material suitable?

Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy

Potential of telomerase expression and activity in cervical specimens as a diagnostic tool

Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: a single center study.

Predictive role of telomerase activity in the clinical outcome of patients with benign lesions of the uterine cervix or CIN.

Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cells

Relevance of Urine Telomerase in the Diagnosis of Bladder Cancer

Role of androgen and estrogen receptors as prognostic and potential predictive markers of ductal carcinoma in situ of the breast

Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy

The Role of CXCR4 in the Prediction of Bone Metastases from Breast Cancer: A Pilot Study

The current role of telomerase in the diagnosis of bladder cancer

Triple negative breast cancer in a poor resource setting in North-Western Tanzania: a preliminary study of 52 patients ⬇️

Urinary biomarkers of non-muscle-invasive bladder cancer: current status and future potential

Urine Telomerase Activity for the Detection of Bladder Cancer in Females

Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary data

Urine telomerase: an important marker in the diagnosis of bladder cancer

Usefulness of immunological detection of the human telomerase reverse transcriptase

What Influences the Choice of Ibrutinib-Rituximab vs Classic Chemoimmunotherapy for Chronic Lymphocytic Leukemia?

What impacts the cost-effectiveness of PD-L1 testing in non-small cell lung cancer?

What is the best clinical pathological score to identify high-risk patients with lobular carcinoma of the breast who are likely to benefit from adjuvant chemotherapy?

What to look for in cell-free DNA from breast cancer patients